Ayurveda Medicine for the management of COVID-19
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/09/036380
- Lead Sponsor
- AMIL PHARMACEUTICALS INDIA Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i. Patients able to take medicines orally.
ii. Patients willing to provide signed informed consent shall be included.
iii. RT-PCR (Reverse transcription polymerase chain reaction) positive patients
Exclusion Criteria
i. Subjects with severe vomiting which would affect oral administration of medicine difficult.
ii. Moderate and severe cases.
iii. Pregnant and lactating subjects.
iv. Subjects with Type 1 diabetes, malignancy and those with advanced liver or kidney disease.
v. The initially included subjects who during the course of treatment progress from mild to moderate category in severity.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. All-cause mortality <br/ ><br>2. WHO Ordinal Scale for Clinical Improvement of COVID-19Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method 1. Virological clearance of nasopharyngeal samples <br/ ><br>2. Admission to critical care unit <br/ ><br>3. Need for supplemental oxygen, mechanical ventilation/oxygenation or ECLS <br/ ><br>4. Need for intravenous vasoactive medications <br/ ><br>5. Need for renal replacement therapy <br/ ><br>6. Hospital-free days, ICU-free daysTimepoint: 1 year